KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation & Amortization (CF) (2016 - 2025)

Pacific Biosciences Of California has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $2.7 million for Q4 2025, down 4.15% from a year ago — trailing twelve months through Dec 2025 was $13.0 million (down 5.8% YoY), and the annual figure for FY2025 was $13.0 million, down 5.8%.
  • Depreciation & Amortization (CF) for Q4 2025 was $2.7 million at Pacific Biosciences Of California, up from $2.5 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PACB hit a ceiling of $5.1 million in Q1 2025 and a floor of $1.6 million in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $2.7 million (2025), compared with a mean of $2.8 million.
  • Peak annual rise in Depreciation & Amortization (CF) hit 58.36% in 2025, while the deepest fall reached 41.31% in 2025.
  • Pacific Biosciences Of California's Depreciation & Amortization (CF) stood at $2.3 million in 2021, then grew by 13.61% to $2.6 million in 2022, then grew by 16.11% to $3.0 million in 2023, then decreased by 3.63% to $2.9 million in 2024, then decreased by 4.15% to $2.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $2.7 million (Q4 2025), $2.5 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.